Clinical Trial Update: Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan and gemcitabine chemotherapy for biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Yonsei University | Conditions: Biliary Tract Cancer | Phase 2 | Status: COMPLETED